A new Primary Care Investment Guide from the Harvard Medical School Center for Primary Care outlines evidence-based strategies for strengthening advanced primary care while improving outcomes and lowering costs. Developed with support from the California Health Care Foundation and the Commonwealth Fund, the guide identifies integrated clinical pharmacy services as a key investment alongside behavioral health, care management and population health.
Searching for Solutions
No summary available
No summary available
No summary available
AAPP and its pharmacy partners urged federal officials to take actions to restore public confidence in the vaccine advisory process. Our joint letter expresses concerns about ACIP's new charter, recommends key reforms, and emphasizes the critical role of the pharmacy workforce in protecting communities from vaccine-preventable diseases.
No summary available
Read the report that recaps 2026 State Legislative Sessions.
No summary available
This report describes the total number of clients receiving mental health and support services in 2024 including demographic characteristics, mental health diagnoses, and select National Outcome Measures (NOMs) for children and adults.
The study examined the general public’s perspectives towards SCS client considerations, community impacts, and health system impacts.
This paper reviews the evidence for injury to the hippocampus associated with opioid use and OUD.
This paper describes the phenomenon of compulsive tanning and its similarities to SUDs.
Findings suggest AI-based preliminary interpretation of urine drug testing results is fast and accurate and may provide substantial efficiency gains to the clinical service.
Increasing geographic availability of medications for opioid use disorder is likely a necessary but not sufficient strategy for addressing variation in access to care.
This trial did not find evidence that the STOP intervention for reducing risky opioid use produced greater reductions over 6 months compared with enhanced usual care.
Among adults receiving legally prescribed or dispensed buprenorphine or methadone, extra-medical use of these same medications was reported at one in every 10 visits.
In this clinical trial, CBT and PRS had no effect on rates of opioid abstinence in the year following the initiation of MOUD.
Findings illuminate points of intervention for alternative approaches to discipline that minimize harm among school-aged youth.
Transgender youth access to health care that is inclusive, gender-affirming, and evidence-based is recommended in AAPP’s newest policy statement along with opposition to “conversion” or “reparative” treatment models which are ineffective, deceptive, and lack in evidence.
In its newest policy statement, AAPP reaffirms support to transgender youth access to health care that is inclusive, gender-affirming, evidence-based, and developmentally appropriate. The statement additionally opposes “conversion” or “reparative” treatment models as ineffective, deceptive, and lack in evidence. Please visit these evidence-based policy asks and use them as the basis for advocacy in your city, state, and federally.
Rescheduling cannabis and psychedelics is recommended by AAPP as means to reduce barriers to rigorous clinical research with the goal to strengthen the evidence base on both benefit and harm.
AAPP’s newest policy requests provide support to rescheduling cannabis and psychedelics to reduce barriers to rigorous clinical research with the goal to strengthen the evidence base on both benefit and harm. Please visit these policy asks and use them as the basis for advocacy in your city, state, and federally.
Gambling disorder and problem gambling research and treatment are needed and supported by AAPP given the limited research on screening and treatment of gambling disorder.
The FDA reversed years of strict enforcement against flavored vapes by authorizing the first legal fruit-flavored e-cigarettes for adults over 21. AAPP supports policies that reduce access to products such as flavored vapes that are attractive to youth.
AAPP has released requests related to implementation of federal policies that reduce access to nicotine-containing products among teens and adolescents including flavored vaping products that increase youth appeal. Additionally, with increased incidence of gambling disorder and problem gambling, AAPP has issued support for increased research into and access to treatment given that there are currently no FDA-approved medications for treatment of gambling disorder.